Hodgson Ian 4

What Happened

• Ian Hodgson, Chief Operating Officer of Corbus Pharmaceuticals (CRBP), sold 2,415 shares on Feb 3, 2026 at a weighted average price of $8.09 for gross proceeds of approximately $19,537. The sale was a sell-to-cover to satisfy tax withholding obligations related to the vesting and settlement of RSUs, not a discretionary open-market sale.

Key Details

• Transaction date: 2026-02-03; Form 4 filed: 2026-02-04.
• Price: weighted average $8.09; actual trade prices ranged from $8.01 to $8.15 (multiple trades).
• Shares sold: 2,415; proceeds ≈ $19,537.
• Purpose: Sell-to-cover for RSU tax withholding (footnote F1); transaction code: S (sale), related to tax withholding.
• Holdings note: filing states there are 48,108 unvested RSUs subject to previously disclosed vesting schedules (footnote F3).
• The filer offers to provide detailed per-price breakdown on request (footnote F2).
• No late filing indicated; transaction reported the next day.

Context

• Sell-to-cover transactions are routine when restricted stock units vest and the issuer requires taxes be paid by selling a portion of the shares; such sales are generally administrative and do not necessarily indicate the insider’s view of the company’s prospects.